Treatment of advanced colorectal cancer in the elderly

European Journal of Surgical Oncology

Volumn 33, Issue SUPPL. 2, 2007, Pages

  Bruce, C ^a   Kohne C H ^b   Audisio, R A ^c  

^a Mersey Deanery   (United Kingdom)

^b KLINIKUM OLDENBURG   (Germany)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Colorectal cancer; Elderly

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; COLORECTAL CANCER; DIARRHEA; FATIGUE; HUMAN; INTERVENTION STUDY; INTESTINE OBSTRUCTION; LIVER METASTASIS; MONOTHERAPY; NAUSEA AND VOMITING; NEUROTOXICITY; NEUTROPENIA; PALLIATIVE THERAPY; PRIORITY JOURNAL; REVIEW; STENT; THROMBOCYTOPENIA;

AGE FACTORS; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; COLECTOMY; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; FLUOROURACIL; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; ORGANOPLATINUM COMPOUNDS; STENTS;

EID: 36749086045     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.09.015     Document Type: Review

References (25)

1. Rosati G. Elderly patients with advanced colorectal cancer: which therapy is the safest?. Expert Opin Drug Saf 4 6 (2005 Nov) 1041-1049
2. Gallego R., Sanchez N., and Maurel J. Chemotherapy for elderly patients with advanced colorectal carcinoma. Expert Rev Anticancer Ther 6 5 (2006 May) 795-800
3. Lewis J.H., Kilgore M.L., Goldman D.P., et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21 (2003) 1383-1389
4. D'Andre S., Sargent D.J., Cha S.S., et al. 5-fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a North Central Cancer Treatment Group study. Clin Colorectal Cancer 4 (2005) 325-331
5. Tournigand C., Andre T., Achille E., et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomised GERCOR study. J Clin Oncol 22 (2004) 229-237
6. Köhne C.H., van Cutsem E., Wils J., et al. Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European organisation for research and treatment of Cancer Gastrointestinal Group study 40986. J Clin Oncol 23 (2005) 4856-4865
7. Grothey A., Sargent D., Goldberg R.M., et al. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 18 (2004) 136-147
8. Goldberg R. Advances in the treatment of metastatic colorectal cancer. Oncologist l0 Suppl. 3 (2005) 40-48
9. Berardi R., Saladino T., Mari D., et al. Elderly patients with advanced colorectal cancer: tolerability and activity of chemotherapy. Tumori 91 6 (2005 Nov-Dec) 463-466
10. Folprecht G., Lutz M.P., Schoffski P., et al. Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth facto receptor expressing metastatic colorectal carcinoma. Ann Oncol 17 (2006) 450-456
11. Chau I., Norman A.R., Cunningham D., et al. Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal caner derive similar benefit without excessive toxicity when treatment with irinotecan monotherapy. Br J Cancer 91 (2004) 1453-1458
12. ® (irinotecan hydrochloride injection) prescribing information. Revised (2006 June), Pharmacia & Upjohn Co
13. Tabah-Fisch I, Maindrault-Goebel F, Benavides M, et al. Oxaliplatin/%FU/LV is feasible, safe and active in elderly colorectal cancer (CRC) patients. ASCO; 2002 [abstract no. 556].
14. Feliu J., and Salud A. Escudero et al. XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer. Br J Cancer 94 7 (2006 April 10) 969-975
15. Goldberg R.M., Tabah-Fisch I., Bleiberg H., et al. Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol 24 25 (2006 September 1) 4085-4091
16. de Gramont A., Figer A., Seymour M., et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18 (2000) 2938-2947
17. van Cutsem E., Twelves C., Cassidy J., et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19 (2001) 4097-4106
18. Jensen S.A., Longborn J.T., and Sorensen J.V. Benefits and risks of palliative capecitabine based therapy to elderly patients with advanced colorectal cancer: Danish single centre experience. Acta Oncol 45 (2006) 67-76
19. Ho C., Ng K., O'Reilly S., and Gill S. Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: a population-based analysis. Clin Colorectal Cancer 5 4 (2005 Nov) 279-282
20. Avastin prescribing information. Available at: (2004), Genentech, San Fransisco, California. http://www.gene.com/gene/products/information/oncology/avastin/insert.jsp
21. Nagano Y., Nojiri K., Matsuo K., et al. The impact of advanced age on hepatic resection of colorectal liver metastases. J Am Coll Surg 201 4 (2005 Oct) 511-516
22. Pavlidis T.E., Marakis G., Ballas K., et al. Safety of bowel resection for colorectal surgical emergency in the elderly. Colorectal Dis 8 8 (2006 Oct) 657-662
23. Tilney H.S., Lovegrove R.E., Purkayastha S., et al. Comparison of colonic stenting and open surgery for malignant large bowel obstruction. Surg Endosc 21 2 (2007 Feb) 225-233
24. Davies R.J., D'Sa I.B., Lucarotti M.E., et al. Bowel function following insertion of self-expanding metallic stents for palliation of colorectal cancer. Colorectal Dis 7 3 (2005 May) 251-253
25. Hunerbein M., Krause M., Noesta K.T., et al. Palliation of malignant rectal obstruction with self-expanding metal stents. Surgery 137 1 (2005 Jan) 42-47